GlassScriptPhysician profile
Raymond H Kuo
NPI 1922033620
$408.80
in general payments reported to CMS, 2019-2025
11 companies · $145 in 2025
The $145 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $48.83 · 2023: $136 · 2024: $78.70 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $78.19 | 2025 | Imfinzi |
| Lilly USA, LLC | $70.62 | 2023-2025 | Jaypirca, Retevmo, Verzenio |
| Janssen Biotech, INC. | $50.43 | 2022-2024 | Darzalex, Tecvayli, Talvey |
| Taiho Oncology, INC. | $32.92 | 2023 | |
| Pharmaessentia USA Corporation | $32.81 | 2024 | Besremi |
| Sobi, INC | $29.51 | 2022 | |
| Bard Peripheral Vascular, INC. | $27.94 | 2023-2024 | Denali Vena Cava Filter, Covera |
| Incyte Corporation | $25.96 | 2025 | Jakafi |
| Eisai INC. | $24.28 | 2023 | |
| Array Biopharma INC | $19.36 | 2025 | Braftovi, Mektovi |
| Kyowa Kirin, INC. | $16.78 | 2023 | Poteligeo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Kuo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.